Skip to content
10-Q

Quarterly Report

GW PHARMACEUTICALS PLC

0001564590-20-024348

← back to feed
Filed
May 11, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Apr 30, 2020 372.96M sh
Cash And Equivalents Q1 2020 · Mar 31, 2020 $500.94M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $536.93M
Current Liabilities Q1 2020 · Mar 31, 2020 $103.47M
Current Liabilities Q1 2020 · Dec 31, 2019 $117.56M
Total Liabilities Q1 2020 · Mar 31, 2020 $139.37M
Total Liabilities Q1 2020 · Dec 31, 2019 $156.22M
Current Assets Q1 2020 · Mar 31, 2020 $672.75M
Current Assets Q1 2020 · Dec 31, 2019 $699.64M
Total Assets Q1 2020 · Mar 31, 2020 $854.38M
Total Assets Q1 2020 · Dec 31, 2019 $882.25M
Shares Diluted Q1 2020 · Mar 31, 2019 369.82M sh
Capex Q1 2020 · Mar 31, 2019 $12.09M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$58.38M
Stockholders Equity Q1 2020 · Mar 31, 2019 $639.73M
Stockholders Equity Q1 2020 · Dec 31, 2018 $674.08M
Eps Diluted Q1 2020 · Mar 31, 2019 −$0.14
Eps Basic Q1 2020 · Mar 31, 2019 −$0.14
Sga Expense Q1 2020 · Mar 31, 2019 $55.08M
Rd Expense Q1 2020 · Mar 31, 2019 $30.38M
Net Income Q1 2020 · Mar 31, 2019 −$50.06M
Operating Income Q1 2020 · Mar 31, 2019 −$51.34M
Cost Of Revenue Q1 2020 · Mar 31, 2019 $5.13M
Revenue Q1 2020 · Mar 31, 2019 $39.25M